How to Target the Right Physicians Using Trigger Programs
As therapies become increasingly complex and personalized, it is imperative that physicians...
As therapies become increasingly complex and personalized, it is imperative that physicians...
While each rare disease individually impacts only 200,000 people or less, with 7,000 known rare...
As life settles into the new normal after the worst of the COVID-19 pandemic, it is clear that...
While it feels like we’re back to a pre-pandemic sense of normal, COVID continues to be an evolving...
With the surge in RSV cases that plagued our nation’s children at record levels this fall and over...
The challenges of the COVID-19 pandemic did bring about some positive impact, accelerating the...
Historically, clinical trial data and real-world data (RWD) have existed in silos. With increasing...
A recent survey by the Deloitte Center for Health Solutions of biopharma executives and other...
Diabetes is a complex disease that affects over 37 million Americans, or 11% of the population, and...
As we honor our military service members this Veterans Day, we take time to reflect on how we can...
The problem with Zombie Data—And the critical need for Verified Data In life sciences, where real-world data (RWD) fuels research, market access, and commercial decision-making, trust in data is everything. Yet, the growing presence of Zombie Data—da...